SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 2, 2026

CTNM

Contineum Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $0.8M total
Actionable Insight • Neutral

This cluster is a vesting-driven sell pattern, not a material bearish signal. Monitor for any follow-on open-market sales by these insiders over the next 30 days; if additional sales occur without prior derivative exercises, the signal would strengthen. The company has no cross-filing context suggesting distress (no NT, no offering, no restatement), so this cluster alone does not warrant a bearish read.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$15.53
T+0 close · Jul 2, 2026 · via day close
Latest settled
−25.95%
T+60 · $11.50
Vs SPY
−27.67%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $15.53entry
  2. T+1 · 4mo ago −6.25%α −5.77% · $14.56
  3. T+5 · 4mo ago −5.86%α −5.58% · $14.62
  4. T+20 · 4mo ago +2.58%α +1.73% · $15.93
  5. T+60 · 7w ago −25.95%α −27.67% · $11.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics exercised and sold shares in a coordinated cluster totaling ~$796K in open-market sales on June 30, 2026. The cluster is entirely sell-side with a clear pattern of derivative exercises paired with immediate share sales, indicating a liquidity/vesting-driven event rather than a uniform bearish conviction call. At ~0.14% of the $570M market cap, the total is modest and within routine proportionality, despite the C-suite breadth.

Key Financial Metrics

Direction
selling
Total Value
$796.0K
Insiders
3

Key Facts

  • Three insiders sold 37,186 shares in open-market sales on June 30- July 1, 2026, totaling ~$796K.
  • CEO Carmine Stengone sold 10,000 shares ($160K); CSO Daniel Lorrain sold 28,826 shares ($462K); CMO Tim Watkins sold 10,833 shares ($174K).
  • Each insider exercised stock options (prices $0-$4.50) immediately prior to or concurrent with the sales, a typical vesting-and-sell pattern.
  • Total open-market sales represent ~0.14% of the company's $570M market cap, below the 0.5% threshold for a notable cluster.

Financial Impact

Total insider sales of $796K, representing 0.14% of market cap; non-cash derivative exercises had no market impact.

dilutioninsider ownership

Risk Factors

  • Insider selling tends to be a weak forward indicator for a single cluster; cluster sells are less informative than cluster buys per the literature.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CTNM-1783063046737

US Market Status

Market Closed · Opens in 7h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026